• HRC2026
  • 11 - 13 Oct 2026

Download Agenda

Sessions

11:30 - 18:45 EP Traces Course Hall 8a
14:00 - 15:30 Arrhythmia Alliance 1 Symposia – New Frontiers and Challenges in Pacing Hall 8b
14:00 - 15:30 Masterclass Devices 1 – Lead Extraction in 2026 – State of the Art Review Executive Room 1
14:00 - 15:30 Oral Abstracts – Evolving Frontiers and Arrhythmia Mechanisms Executive Room 2
16:00 - 17:30 AF Association 1 Symposia – Looking at AF Management Across the Population – From Start to Finish! Hall 8b
16:00 - 17:30 Strategies for VT Ablation: Mapping, Ablation Tools, and Procedural Workflows Executive Room 1
16:00 - 17:30 Oral Abstracts - Arrhythmia Clinical Executive Room 2

EP Traces Course - Hall 8a - 11:30 - 18:45

Chair: Dr Dewi Thomas, Dr Ruairidh Martin, Dr Simon Modi Swansea, UK, Newcastle Upon Tyne, UK, Liverpool, UK
11:30 Welcome, course objectives and ‘How to approach the unknown tracing’
11:45 EP traces session 1 - 4 (please note there will be lunch, followed by 1 x break throughout the day)
18:45 Close

Arrhythmia Alliance 1 Symposia – New Frontiers and Challenges in Pacing Arrhythmia Alliance 1 Symposia – New Frontiers and Challenges in Pacing - Hall 8b - 14:00 - 15:30

Chair: Dr Mark Tanner, Dr Nadine Ali Chichester, UK, High Wycombe, UK
14:00 Should I be aiming for physiological atrial pacing? Dr Badrinathan Chandrasekaran Swindon, UK
14:10 My approach to Bachmann’s bundle pacing Dr Ahran Arnold London, UK
14:20 Current state of the art in leadless pacing: which patients, what approach? Dr Jenny Chuen Nottingham, UK
14:30 Leadless service: enhancing equity and ease of access Dr Badrinathan Chandrasekaran Swindon, UK
14:40 Which pacing approach should I use for bradycardia indication and LVEF between 35–50%? (recorded presentation) Prof Valentina Kutyifa Rochester, US
14:50 Extract or jail? – Managing pacing leads prior to tricuspid valve intervention Prof Aldo Rinaldi London, UK
15:00 CIEDs upgrades and downgrades: what does EHRA advise? Dr Daniel Keene London, UK
15:10 Final discussion
15:30 Close

Masterclass Devices 1 – Lead Extraction in 2026 – State of the Art Review - Executive Room 1 - 14:00 - 15:30

Chair: Dr Lisa Leung, Prof Mark Gallagher London, UK, London, UK
14:00 Who needs a lead extraction procedure – indications in 2026
Infection, malfunctioning systems, preserving access and SVC syndrome
Abandon or extract? – initiating the debate on abandonment versus extraction
Review of the evidence and guidelines
Dr Zia Zuberi London, UK
14:20 Preparation for extractions – what information is vital for extractors from non-extractors?
The dilemma of re-implantation – externalised TPW, Micra, CRT vs CSP and contralateral implant in the same sitting
Review of the evidence and cases
Dr Jonathan Behar London, UK
14:40 Modern TLE – advances in lead extraction techniques
Tandem, jugular, femoral and snaring techniques – case-based discussion
Dr Zaki Akhtar London, UK
15:00 Safety in transvenous lead extraction – associated risks, complications and strategies to reduce overall risk
SVC balloon, cardiopulmonary bypass, AngioVac for large vegetations/clots and surgical backup in the room or on standby
What to do in pacing-dependent patients – the St George’s temporary pacing system
Dr Manav Sohal London, UK
15:20 Final discussion
15:30 Close

Oral Abstracts – Evolving Frontiers and Arrhythmia Mechanisms - Executive Room 2 - 14:00 - 15:30

Chair: Dr Gavin Chu, Dr Shamil Yusuf Blackpool, UK, Coventry, UK
14:00 Concordant electrical and structural atrial remodelling confers 26 fold higher odds of atrial fibrillation: a four-phenotype classification Sadees Clarance Chandran Dalian, CN
14:15 Clinical characteristics and ablation outcomes in patients with right atrial cardiomyopathy Jing Hu Nanchang, CN
14:30 A high-definition unipolar intracardiac electrogram processing algorithm Qindong Zheng London, UK
14:45 Association of GLP-1 receptor agonist therapy with atrial fibrillation risk in patients with stage 3–4 chronic kidney disease Ranokhon Igamberdiyeva Tashkent, UZ
15:00 Explainable machine learning for AF detection using ECG remodelling markers: false positives reveal subclinical atrial myopathy Sadees Clarance Chandran Dalian, CN
15:15 Tau20-RETROmapping system reliably identifies organised wavefronts during atrial fibrillation to produce live beat-to-beat activation maps Fatima Nadeem London, UK
15:30 Close

AF Association 1 Symposia – Looking at AF Management Across the Population – From Start to Finish! AF Association 1 Symposia – Looking at AF Management Across the Population – From Start to Finish! - Hall 8b - 16:00 - 17:30

Chair: Dr Milena Leo, Dr Shouvik Haldar Portsmouth, UK, London, UK
16:00 Pulsed field ablation for PVI: hype, evidence, and real-world adoption Dr Davide Fabbricatore London, UK
16:15 Antiarrhythmic drugs in real-world practice: Expert guidance for understudied clinical scenarios from the new HRS scientific statement Dr Daniel Morin San Francisco, US
16:30 The arrhythmia nurse specialist’s role in modern AF pathways Dr Angela Griffiths Oxford, UK
16:45 Population screening for AF (recorded presentation) Dr Damian Redfearn Ottawa, CA
17:00 Revolutionising the Standard of Care: AI-Driven 12-Lead ECG Acquisition via the Kardia 12L System Dr Yassir Javaid Northampton, UK
17:15 Final discussion
17:30 Close

Strategies for VT Ablation: Mapping, Ablation Tools, and Procedural Workflows - Executive Room 1 - 16:00 - 17:30

Chair: Dr Moloy Das, Prof Tarv Dhanjal Newcastle Upon Tyne, UK, Coventry, UK
16:00 Differentiating VT substrates: A mechanistic approach to ablation Dr Johanna Tonko London, UK
16:15 Are all substrate mapping methods equally effective? Mr Joseph Mayer Stoke On Trent, UK
16:30 Early experience of a RF/PF lattice catheter Dr Vishal Luther Liverpool, UK
16:45 Debate: an endo-epi approach should be performed first-line for VT ablation. PRO Prof John Silberbauer Brighton, UK
17:00 Debate: an endo-epi approach should be performed first-line for VT ablation. CON Dr Gareth Padfield Glasgow, UK
17:15 Final discussion
17:30 Close

Oral Abstracts - Arrhythmia Clinical - Executive Room 2 - 16:00 - 17:30

Chair: Dr Shamil Yusuf, Dr Shui Hao Chin Coventry, UK, Leicester, UK
16:00 Outcomes in catheter ablation and conservative management after ICD therapies in patients with structural heart disease: a single-centre real-world experience Timothy Jones Southampton, UK
16:15 HCM-SCD risk change and arrhythmic outcomes after mavacamten therapy in hypertrophic obstructive cardiomyopathy Hou Mak Newcastle Upon Tyne, UK
16:30 Does the CARTOSOUND FAM automated algorithm generate a more accurate reconstruction of left atrial anatomy than conventional manual assessment of intracardiac Mike Lawless Middlesbrough, UK
16:45 Pacing-induced severe functional mitral regurgitation after “ablate and pace” with a leadless pacemaker: reversal with endocardial resynchronisation Thet Hnin Middlesbrough, UK
17:00 SCOPE-15: Syncope comorbidity outcomes and pacemaker evolution – a 15-year retrospective cohort study of ILR monitoring Ana Correia Chertsey, UK
17:15 Fixation beats do not predict physiological conduction system capture in left bundle branch area pacing Gareth Davies Swansea, UK
17:30 Close